Safety and Performance of the Aortix™ Device in Patients With Decompensated Heart Failure and Cardiorenal Syndrome
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Biotronik; Medtronic; Abbott Vascular; Zoll
- Equity/Stock(s)/Options - Procyrion